Daniel Lee Flynn - Chief Scientific Officer at Deciphera Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
DCPH
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel Lee Flynn since 9/18/2023

Holdings reported by Daniel Lee Flynn for Deciphera Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 181K $2.62M $14.47 Jun 16, 2023 By Daniel L. Flynn Revocable Trust
Common Stock 91K $1.32M $14.47 Jun 16, 2023 By Daniel L. Flynn Irrevocable Trust
Common Stock 57.2K $827K $14.47 Jun 16, 2023 Direct
Common Stock 49.5K $716K $14.47 Jun 16, 2023 By GRAT
Stock Option (Right to Buy) 65.9K $697K $10.58 Feb 15, 2023 Direct Common Stock

Transactions reported by Daniel Lee Flynn for Deciphera Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.